Please login to order a test.
PD-L1, IHC (Atezolizumab), Non-Small-cell Lung Cancer
- Programmed Death Ligand 1
The PD-L1 (SP142) is a qualitative IHC assay intended for use in the detection of PD-L1 in formalin-fixed, paraffin embedded (FFPE) in non-small-cell lung cancer tissue samples using the Ventana BenchMark Ultra Platform.
Immunohistochemistry using Ventana BenchMark Ultra.
Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides
At least two unstained slides sectioned at 4 microns, less than two months of sectioning if stored at 15°C to 30°C. Four slides are ideal.
Two unstained slides at 4 microns, less than two months of sectioning if stored at 15°C to 30°C.
Paraffin block or unstained slides sectioned if stored at 15°C to 30°C for two months age.
Causes for Rejection
Slides sectioned more than two months prior to test request and not stored at 15°C to 30°C
PD-L1 testing will be delayed if the pathology report is not received.
Note: This test number is used for tracking oncology IHC specimens to the laboratory. Bill codes will be added when testing is complete, based on the processes performed in the laboratory.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|451949||PD-L1 IHC, TECENTRIQ (TM)Lung||85149-3||451944||Result||83057-0|
|451949||PD-L1 IHC, TECENTRIQ (TM)Lung||85149-3||451945||% Tumor Cells Staining:||%||83053-9|
|451949||PD-L1 IHC, TECENTRIQ (TM)Lung||85149-3||451946||Comment||77202-0|
|451949||PD-L1 IHC, TECENTRIQ (TM)Lung||85149-3||451947||Interpretation||77202-0|
|451949||PD-L1 IHC, TECENTRIQ (TM)Lung||85149-3||451948||Director Review||72486-4|